Newborn Screening Market is on an Upward Growth Curve

"Newborn Screening Market" in terms of revenue was estimated to be worth 935.17 Million in 2022 and is poised to reach 2113.45 Million by the year 2031, growing at a CAGR of 9.8 % from 2023 to 2031 according to a new report by Insight Ace Analytic.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1433

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Newborn Screening market are:
• An increasing number of newborns
• Increasing prevalence of newborn disorders
• Technical improvements

The following are the primary obstacles to the Newborn Screening market's expansion:
• The lack of uniformity in newborn screening
• High cost associated with newborn screening instruments
• The lack of standardized protocols

Future expansion opportunities for the global Newborn Screening market include:
• Introduction of new advanced technology
• Emerging markets
• Favorable government laws and policies

Key Industry Insights & Findings from the Report:
• The need for newborn screening market is due to rising incidences of congenital diseases, and advancements in technologies for newborn screening.
• The increase in prevalence of congenital illnesses in infants is expected to drive industry growth.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• One of the significant concerns restraining industry growth is the high cost related to newborn screening instruments.

Market Analysis:
The global market for newborn screening is expected to witness robust growth in the coming years, fueled by enhanced governmental initiatives and technological breakthroughs in diagnostic screening methods. A combination of rising birth rates and an uptick in neonatal health conditions continues to drive demand for early testing.

The expansion of genetic disorder screening, coupled with increasing investment and healthcare awareness in developing regions, is creating new growth avenues. These markets benefit from both higher birth volumes and growing household incomes, making them attractive targets for industry development and innovation.

List of Prominent Players in the Newborn Screening Market:
• Perkinelmer, Inc.
• Waters Corporation
• Natus Medical Incorporated
• Ab Sciex LLC
• Masimo Corporation
• Bio-Rad Laboratories, Inc.
• Covidien Plc
• Ge Healthcare
• Trivitron Healthcare
• Agilent Technologies Inc.

Recent Developments:
• In August 2022, Trivitron Healthcare launched a Centre of Excellence (CoE) with state-of-the-art R&D and manufacturing facilities at AMTZ Campus, Vishakhapatnam, India, for metabolomics, genomics, newborn screening, and molecular diagnostics.
• In June 2022, Rady Children's Institute for Genomic Medicine introduced a program to advance and evaluate the scalability of a diagnostic and precision medicine guidance tool called BeginNGS to screen newborns for around 400 genetic diseases with known treatment options using rapid whole genome sequencing.
• In June 2022, Novartis AG began with a partnership with the American Society of Hematology (ASH) to supply six additional African nations with the technology that is already being used in Ghana to document and share the diagnosis of babies with sickle cell disease. This partnership expands the current newborn screening consortium to new areas.

Newborn Screening Market Dynamics:
Market Drivers: Rising Incidence of Newborn Disorders
The rising number of neonatal health conditions has significantly boosted demand for sophisticated newborn screening technologies. Common conditions such as metabolic imbalances, auditory impairments, hormonal disorders, and congenital heart issues can often be managed successfully if identified early. This has reinforced the adoption of screening programs globally. Additionally, growing awareness about the benefits of early detection is encouraging parents and healthcare providers to prioritize newborn screening.

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1433

Challenges: High Costs and Regulatory Complexity
Despite its benefits, the newborn screening market faces hurdles, particularly the high costs of diagnostic equipment and procedures. These financial barriers are especially challenging for lower-income regions. In response, market players are increasingly focusing on the development of affordable, safe, and efficient screening solutions.

Regional Trends: North America to Lead Market Growth
North America is expected to dominate the global newborn screening market, showing strong growth throughout the forecast period. This leadership is driven by a high rate of birth defects, favorable government initiatives, an advanced healthcare system, and the presence of established industry players. The United States, in particular, is projected to hold the largest share due to the implementation of widespread state-level newborn screening programs and rising incidences of neonatal disorders. Continued innovation and investment in early detection technologies are poised to further bolster the region's market leadership.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1433

Segmentation of Newborn Screening Market-
By Product-
• Instruments
• Reagents
• Assay kits
• Others
By Technology-
• Tandem Mass Spectrometry
• Pulse Oximetry Screening
• Enzyme based Assay
• DNA Assay
• Electrophoresis
• Others
By Test Type-
• Dry Blood Spot Test
• Critical Congenital Heart Diseases
• Hearing Screen
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information:
https://www.insightaceanalytic.com/report/global-newborn-screening-market/1433

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.